Novel immunologic adjuvants:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London
Future Medicine Ltd
c2011
|
| Schriftenreihe: | Future Science Group eBook collection
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Beschreibung: | Includes bibliographical references and index Novel immunologic adjuvants / R. Rappuoli & E. De Gregorio -- Rationales for including adjuvants in vaccines / V.E.J.C. Schijns & E.C. Lavelle -- New alum combinations / S. Awate, N.F. Eng & G.K. Mutwiri -- Oil emulsions as vaccine adjuvants / J. Haensler -- Virosomes / C. Moser -- Saponin QS-21 adjuvants in cancer vaccines / G. Ragupathi, J.R. Gardner, D.Y. Gin & P.O. Livingston -- TLR4 agonists as effective vaccine adjuvants / J. Baldridge -- TLR7/8 agonists / M.A. Tomai & J.P. Vasilakos -- TLR9 agonists / G. Zhao, D. Tross & D.M. Klinman -- Future trends of novel vaccine adjuvants / V.E.J.C. Schijns & E.C. Lavelle |
| Beschreibung: | 1 electronic text (119 p.) col. ill., digital file |
| ISBN: | 9781780840048 9781780840055 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV039836330 | ||
| 003 | DE-604 | ||
| 005 | 20160308 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 120124s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 9781780840048 |c pdf |9 978-1-78084-004-8 | ||
| 020 | |a 9781780840055 |9 978-1-78084-005-5 | ||
| 024 | 7 | |a 10.2217/9781780840048 |2 doi | |
| 035 | |a (OCoLC)759693133 | ||
| 035 | |a (DE-599)BVBBV039836330 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 615/.372 |2 2 | |
| 084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Novel immunologic adjuvants |c editors, Rino Rappuoli, Ennio De Gregorio |
| 264 | 1 | |a London |b Future Medicine Ltd |c c2011 | |
| 300 | |a 1 electronic text (119 p.) |b col. ill., digital file | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Future Science Group eBook collection | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Novel immunologic adjuvants / R. Rappuoli & E. De Gregorio -- Rationales for including adjuvants in vaccines / V.E.J.C. Schijns & E.C. Lavelle -- New alum combinations / S. Awate, N.F. Eng & G.K. Mutwiri -- Oil emulsions as vaccine adjuvants / J. Haensler -- Virosomes / C. Moser -- Saponin QS-21 adjuvants in cancer vaccines / G. Ragupathi, J.R. Gardner, D.Y. Gin & P.O. Livingston -- TLR4 agonists as effective vaccine adjuvants / J. Baldridge -- TLR7/8 agonists / M.A. Tomai & J.P. Vasilakos -- TLR9 agonists / G. Zhao, D. Tross & D.M. Klinman -- Future trends of novel vaccine adjuvants / V.E.J.C. Schijns & E.C. Lavelle | ||
| 650 | 4 | |a Immunological adjuvants | |
| 650 | 4 | |a Immune response / Regulation | |
| 650 | 4 | |a Vaccines | |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zusatz |0 (DE-588)4132717-2 |2 gnd |9 rswk-swf |
| 653 | |a Electronic books | ||
| 689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | 1 | |a Zusatz |0 (DE-588)4132717-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Rappuoli, Rino |d 1952- |e Sonstige |0 (DE-588)108239985X |4 oth | |
| 700 | 1 | |a De Gregorio, Ennio |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.futuremedicine.com/doi/book/10.2217/9781780840048 |x Verlag |3 Volltext |
| 912 | |a ZDB-81-FSG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024696318 | ||
| 966 | e | |u http://www.futuremedicine.com/doi/book/10.2217/9781780840048 |l UBR01 |p ZDB-81-FSG |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804148766419189760 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)108239985X |
| building | Verbundindex |
| bvnumber | BV039836330 |
| classification_rvk | XD 3300 |
| collection | ZDB-81-FSG |
| ctrlnum | (OCoLC)759693133 (DE-599)BVBBV039836330 |
| dewey-full | 615/.372 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.372 |
| dewey-search | 615/.372 |
| dewey-sort | 3615 3372 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02394nmm a2200493zc 4500</leader><controlfield tag="001">BV039836330</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160308 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">120124s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840048</subfield><subfield code="c">pdf</subfield><subfield code="9">978-1-78084-004-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781780840055</subfield><subfield code="9">978-1-78084-005-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2217/9781780840048</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)759693133</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV039836330</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.372</subfield><subfield code="2">2</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel immunologic adjuvants</subfield><subfield code="c">editors, Rino Rappuoli, Ennio De Gregorio</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Future Medicine Ltd</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic text (119 p.)</subfield><subfield code="b">col. ill., digital file</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Future Science Group eBook collection</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Novel immunologic adjuvants / R. Rappuoli & E. De Gregorio -- Rationales for including adjuvants in vaccines / V.E.J.C. Schijns & E.C. Lavelle -- New alum combinations / S. Awate, N.F. Eng & G.K. Mutwiri -- Oil emulsions as vaccine adjuvants / J. Haensler -- Virosomes / C. Moser -- Saponin QS-21 adjuvants in cancer vaccines / G. Ragupathi, J.R. Gardner, D.Y. Gin & P.O. Livingston -- TLR4 agonists as effective vaccine adjuvants / J. Baldridge -- TLR7/8 agonists / M.A. Tomai & J.P. Vasilakos -- TLR9 agonists / G. Zhao, D. Tross & D.M. Klinman -- Future trends of novel vaccine adjuvants / V.E.J.C. Schijns & E.C. Lavelle</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunological adjuvants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune response / Regulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zusatz</subfield><subfield code="0">(DE-588)4132717-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Zusatz</subfield><subfield code="0">(DE-588)4132717-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rappuoli, Rino</subfield><subfield code="d">1952-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)108239985X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Gregorio, Ennio</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.futuremedicine.com/doi/book/10.2217/9781780840048</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-81-FSG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024696318</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.futuremedicine.com/doi/book/10.2217/9781780840048</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-81-FSG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV039836330 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T00:12:21Z |
| institution | BVB |
| isbn | 9781780840048 9781780840055 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024696318 |
| oclc_num | 759693133 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 electronic text (119 p.) col. ill., digital file |
| psigel | ZDB-81-FSG |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Future Medicine Ltd |
| record_format | marc |
| series2 | Future Science Group eBook collection |
| spelling | Novel immunologic adjuvants editors, Rino Rappuoli, Ennio De Gregorio London Future Medicine Ltd c2011 1 electronic text (119 p.) col. ill., digital file txt rdacontent c rdamedia cr rdacarrier Future Science Group eBook collection Includes bibliographical references and index Novel immunologic adjuvants / R. Rappuoli & E. De Gregorio -- Rationales for including adjuvants in vaccines / V.E.J.C. Schijns & E.C. Lavelle -- New alum combinations / S. Awate, N.F. Eng & G.K. Mutwiri -- Oil emulsions as vaccine adjuvants / J. Haensler -- Virosomes / C. Moser -- Saponin QS-21 adjuvants in cancer vaccines / G. Ragupathi, J.R. Gardner, D.Y. Gin & P.O. Livingston -- TLR4 agonists as effective vaccine adjuvants / J. Baldridge -- TLR7/8 agonists / M.A. Tomai & J.P. Vasilakos -- TLR9 agonists / G. Zhao, D. Tross & D.M. Klinman -- Future trends of novel vaccine adjuvants / V.E.J.C. Schijns & E.C. Lavelle Immunological adjuvants Immune response / Regulation Vaccines Impfstoff (DE-588)4026655-2 gnd rswk-swf Zusatz (DE-588)4132717-2 gnd rswk-swf Electronic books Impfstoff (DE-588)4026655-2 s Zusatz (DE-588)4132717-2 s DE-604 Rappuoli, Rino 1952- Sonstige (DE-588)108239985X oth De Gregorio, Ennio Sonstige oth http://www.futuremedicine.com/doi/book/10.2217/9781780840048 Verlag Volltext |
| spellingShingle | Novel immunologic adjuvants Immunological adjuvants Immune response / Regulation Vaccines Impfstoff (DE-588)4026655-2 gnd Zusatz (DE-588)4132717-2 gnd |
| subject_GND | (DE-588)4026655-2 (DE-588)4132717-2 |
| title | Novel immunologic adjuvants |
| title_auth | Novel immunologic adjuvants |
| title_exact_search | Novel immunologic adjuvants |
| title_full | Novel immunologic adjuvants editors, Rino Rappuoli, Ennio De Gregorio |
| title_fullStr | Novel immunologic adjuvants editors, Rino Rappuoli, Ennio De Gregorio |
| title_full_unstemmed | Novel immunologic adjuvants editors, Rino Rappuoli, Ennio De Gregorio |
| title_short | Novel immunologic adjuvants |
| title_sort | novel immunologic adjuvants |
| topic | Immunological adjuvants Immune response / Regulation Vaccines Impfstoff (DE-588)4026655-2 gnd Zusatz (DE-588)4132717-2 gnd |
| topic_facet | Immunological adjuvants Immune response / Regulation Vaccines Impfstoff Zusatz |
| url | http://www.futuremedicine.com/doi/book/10.2217/9781780840048 |
| work_keys_str_mv | AT rappuolirino novelimmunologicadjuvants AT degregorioennio novelimmunologicadjuvants |